Background: Obesity and its comorbidities are considered one of the major health tolls. Bariatric surgery offers significant and long-lasting weight loss as well as significant enhancements in glycemic management for severely obese individuals with type 2 diabetes mellitus. The single anastomosis sleeve jejunal (SASJ) bypass procedure is a novel form of bariatric surgery, it combines both malabsorptive and restrictive techniques. Aim: To evaluate the efficacy of laparoscopic SASJ bypass as a novel bariatric procedure for managing type 2 diabetes mellitus in morbidly obese patients during the first year following surgery. Patients and Methods: The current combined prospective and retrospective study was conducted at Mansoura University Gastrointestinal Surgical Center from December 2019 to January 2023. A total of 25 patients were included in the study. They were diagnosed clinically with primary morbid obesity with a body mass index (BMI) greater than 35 kg/m2 and documented type 2 diabetes mellitus All patients underwent laparoscopic SASJ procedure and were followed-up for 1 year after the operation. Results: The SASJ procedure was associated with significant weight loss outcomes, as the % excess weight loss (% EWL) was 26.29, 41.47, 53.33, and 67.52% at 3-, 6, 9-, 12-month follow-up visits, respectively, and % total weight loss (%TWL) values of 19.16, 30.16, 38.76, and 50.71% at the same intervals. Glycated hemoglobin, fasting blood sugar, and postprandial blood sugar showed a significant decrease at the scheduled follow-up visits compared with the baseline values. At 1-year follow-up, complete remission, partial remission, and improvement of diabetes were detected in 32, 40, and 28% of cases, respectively. Conclusion: The SASJ is a safe bariatric procedure that is associated with low morbidity rates. Besides excellent weight loss outcomes, it yields a beneficial impact on diabetes.
K. Gohar, A., S. Kandil, T., Ezzat, H., & A. Ali, M. (2024). Short and intermediate-term effects of laparoscopic single anastomosis sleeve-jejunal bypass on type 2 diabetic morbidly obese patients.. The Egyptian Journal of Surgery, 43(4), 1351-1357. doi: 10.21608/EJSUR.2024.287279.1064
MLA
Ahmed K. Gohar; Tharwat S. Kandil; Helmy Ezzat; Mahmoud A. Ali. "Short and intermediate-term effects of laparoscopic single anastomosis sleeve-jejunal bypass on type 2 diabetic morbidly obese patients.", The Egyptian Journal of Surgery, 43, 4, 2024, 1351-1357. doi: 10.21608/EJSUR.2024.287279.1064
HARVARD
K. Gohar, A., S. Kandil, T., Ezzat, H., A. Ali, M. (2024). 'Short and intermediate-term effects of laparoscopic single anastomosis sleeve-jejunal bypass on type 2 diabetic morbidly obese patients.', The Egyptian Journal of Surgery, 43(4), pp. 1351-1357. doi: 10.21608/EJSUR.2024.287279.1064
VANCOUVER
K. Gohar, A., S. Kandil, T., Ezzat, H., A. Ali, M. Short and intermediate-term effects of laparoscopic single anastomosis sleeve-jejunal bypass on type 2 diabetic morbidly obese patients.. The Egyptian Journal of Surgery, 2024; 43(4): 1351-1357. doi: 10.21608/EJSUR.2024.287279.1064